Brian Gabrielli

15PUBLICATIONS
46CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)ChemotherapyMolecular targetsChemical and thermal processes in energy and combustion
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (15)

|Jul 10, 2026
S-phase targeted treatment triggers caspase-dependent lytic immunogenic cell death with pyroptotic features in cancers.

|Apr 07, 2026
Using targeted therapy to promote a pro-inflammatory tumour microenvironment and anti-tumour immune response in high grade serous ovarian cancer.

Zhen Zeng, Anastasia Gandini, Rituparna Bhatt

|Jun 13, 2025
Checkpoint Kinase 1 Inhibitor Combined with Low Dose Hydroxyurea Promotes ATM-Activated NF-κB-Dependent Pro-Inflammatory Chemokine Expression in Melanomas.

Nicole Lisa Li-Ann Goh, Nur Jannah Abdul Rahim, Rituparna Bhatt

|Jan 08, 2025
Aurora B inhibition induces hyper-polyploidy and loss of long-term proliferative potential in RB and p53 defective cells.

Shivam Vora, Saptarshi Chatterjee, Ariel Andrew

|Nov 09, 2024
Aurora B inhibitors promote RB hypophosphorylation and senescence independent of p53-dependent CDK2/4 inhibition.

Shivam Vora, Ariel Andrew, Ramyashree Prasanna Kumar

|Feb 10, 2024
The ATM Ser49Cys Variant Effects ATM Function as a Regulator of Oncogene-Induced Senescence.

Caroline Atkinson, Aideen M McInerney-Leo, Martina Proctor

Pageof 3

Frequent Collaborators

4 joint publications

John D Hooper

3 joint publications

Zhen Zeng

3 joint publications

Mathew Jk Jones

3 joint publications

Nikolas K Haass